1. Academic Validation
  2. Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor

Cysteine-Rich α-Conotoxin SII Displays Novel Interactions at the Muscle Nicotinic Acetylcholine Receptor

  • ACS Chem Neurosci. 2022 Apr 20;13(8):1245-1250. doi: 10.1021/acschemneuro.1c00857.
Patrick Wilhelm 1 Karen Luna-Ramirez 2 Yanni K-Y Chin 1 3 Zoltan Dekan 1 Nikita Abraham 1 Han-Shen Tae 2 Chun Yuen Chow 1 David A Eagles 1 Glenn F King 1 Richard J Lewis 1 David J Adams 2 Paul F Alewood 1
Affiliations

Affiliations

  • 1 Institute for Molecular Bioscience, The University of Queensland, St Lucia, QLD 4072, Australia.
  • 2 Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Wollongong, NSW 2522, Australia.
  • 3 Centre for Advanced Imaging, The University of Queensland, St Lucia, QLD 4072, Australia.
Abstract

α-Conotoxins that target muscle nicotinic acetylcholine receptors (nAChRs) commonly fall into two structural classes, frameworks I and II containing two and three disulfide bonds, respectively. Conotoxin SII is the sole member of the cysteine-rich framework II with ill-defined interactions at the nAChRs. Following directed synthesis of α-SII, NMR analysis revealed a well-defined structure containing a 310-helix frequently employed by framework I α-conotoxins; α-SII acted at the muscle nAChR with half-maximal inhibitory concentrations (IC50) of 120 nM (adult) and 370 nM (fetal) though weakly at neuronal nAChRs. Truncation of α-SII to a two disulfide bond amidated peptide with framework I disulfide connectivity led to similar activity. Surprisingly, the more constrained α-SII was less stable under mild reducing conditions and displayed a unique docking mode at the nAChR.

Keywords

biological activity; conotoxin; nicotinic acetylcholine receptor; peptide structure.

Figures
Products